Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

ERIBULIN vs ERYTHROMYCIN ETHYLSUCCINATE: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

ERIBULIN vs ERYTHROMYCIN ETHYLSUCCINATE: Safety Overview

Metric ERIBULIN ERYTHROMYCIN ETHYLSUCCINATE
Total FAERS Reports 5,055 258
Deaths Reported 793 8
Death Rate 15.7% 3.1%
Hospitalizations 2,642 47
Average Patient Age 57.3 yrs 39.1 yrs
% Female Patients 93.0% 73.9%
FDA Approval Date Apr 5, 2024 Approved Prior to Jan 1, 1982
Manufacturer Gland Pharma Limited Azurity Pharmaceuticals, Inc. (former...
Route INTRAVENOUS ORAL
Marketing Status Prescription Prescription